Stereotactic Intracerebral Injection of IPSC-DAPs in Patients with Parkinson's Disease
Clinical trial NCT06821529 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06821529
- Sponsor
- iCamuno Biotherapeutics Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-15
- Primary completion
- 2025-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.